New Orleans to Promote City’s Bio-Boom

The New Orleans BioInnovation Center is embarking on a new campaign to lure bio industry workers back to the city.

Read more »

Brocair Publishes New Report on Generics Market

Brocair Partners LLC, an investment bank serving the healthcare industry, has published a new report on the generic pharmaceuticals sector.

Read more »

BioNeutral to Expand Into Asia

BioNeutral Group, a developer of chemical-based technology, announced that they will form a new wholly owned subsidiary in Hong Kong to commercialize their proprietary chemical formulations throughout Asia.

Read more »

OneMedPlace at 2009 BIO International Convention

OneMedPlace will be covering the 2009 BIO International Convention, the largest biotechnology event in the world. The BIO International Convention attracts […]

Read more »

China Becoming Hot Spot for Western Pharma, Biotech Firms

Asian countries such as India and Japan have gained notoriety for their talented scientists and innovative contributions to the life sciences. Now, a new contender is emerging as a potential industry leader.

Read more »

Bioject Signs With U.S. Navy for Malaria Vaccine

Bioject Medical Technologies, a developer of needle-free injection systems, has signed a cooperative R&D agreement with the U.S. Navy to use Bioject’s technology in a malaria vaccine the Navy is developing.

Read more »

Electro-Optical Announces MelaFind Study Results

Electro-Optical Sciences has announced positive results in a clinical trial of the MelaFind System, a handheld imaging device that detects melanomas at an early stage.

Read more »

Psilos Releases Forecast for Healthcare Industry

Healthcare venture capital firm Psilos has released their first annual report on the issues that will shape healthcare investing in 2009 and beyond.

Read more »

AstraZeneca’s Heart Drug Beats Plavix in Phase III Study

Blood-thinning drug Plavix racks up over $8 billion in annual sales, but the blockbuster medication may have some new competition.

Read more »

Covidien to Buy VNUS Medical Technologies

Forbes reports that medical device maker Covidien is buying VNUS Technologies for $440 million in cash.

Read more »